Arrowhead Research ARWR Enterprise value

Enterprise value at other companies

Ionis PharmaceuticalsIONS

$13.02B+91.2%

ALN

Alnylam PharmaceuticalsALNY

$38.74B-6.7%

Assembly BiosciencesASMB

$411.56M+702%

Arbutus Biopharma CorporationABUS

$856.58M+35.5%

Ultragenyx PharmaceuticalRARE

$1.83B-51.1%

Beam TherapeuticsBEAM

$2.39B+51.2%

FAQ

What is Arrowhead Research's enterprise value?

Arrowhead Research (ARWR) reported enterprise value of $8.7B in Q1 2026.

How has Arrowhead Research's enterprise value changed year-over-year?

Arrowhead Research's enterprise value increased by 418.4% year-over-year, from $1.68B to $8.7B.

What is the long-term trend for Arrowhead Research's enterprise value?

Over 4 years (2021 to 2025), Arrowhead Research's enterprise value has grown at a -7.5% compound annual growth rate (CAGR), from $6.37B to $4.65B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.